On Apr. 14, 2020, Meridian Bioscience announced it had launched a series of recombinant antigens for high sensitivity and specificity IgG/IgM COVID-19 antibody tests. Since the emergence of COVID-19 outbreaks in January, Meridian supported molecular diagnostic companies with critical master mixes and enzymes for their COVID-19 molecular diagnostics tests.